Krebs Biochemicals & Industries Ltd.
Snapshot View

100.00 -4.05 ▼-3.9%

27 January 2023, 04:01:00 PM
Volume: 2,177

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.krebsbiochem.com
Market Cap 215.61 Cr.
Enterprise Value(EV) 389.31 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -16.91 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share -40.49 Trailing Twelve Months Ending 2022-09
Price to Book Value -2.47 Calculated using Price: 100.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.16 Cr. 21,560,586 Shares
FaceValue 10
Company Profile
Krebs Biochemicals & Industries (KBIL) was established in the year 1991 as a Public Limited Company with the main objective of establishing commercially viable biotech processes with applications in Medicine, Agriculture Industry. The company has pioneered in the fermentation technology over the last decade.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.89%
1 Week
-5.26%
1 Month
-8.38%
3 Month
-4.76%
6 Month
-11.50%
1 Year
-43.55%
2 Year
-15.65%
5 Year
-30.47%
10 Year
+372.37%
9 years 2014-09 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -75.26 -683.34 -296.70
Return on Capital Employed (%) -3.91 -4.33 -25.38 -27.13 -28.95 -35.41 -56.96 -40.28 -57.29
Return on Assets (%) -3.19 -6.44 -14.60 -13.46 -14.38 -14.92 -20.91 -19.36 -25.51

Balance Sheet View Details >>

Particulars 10 years 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4 18 13 1 -18 -14 -25 -43 -75 -87
Non Curr. Liab. 23 60 74 89 101 102 116 154 187 216
Curr. Liab. 110 29 30 32 42 55 43 48 78 54
Minority Int.
Equity & Liab. 136 107 116 122 126 142 134 159 190 183
Non Curr. Assets 98 92 107 109 109 111 115 138 154 158
Curr. Assets 39 15 9 13 17 31 19 21 35 25
Misc. Exp. not W/O
Total Assets 136 107 116 122 126 142 134 159 190 183

Profit Loss View Details >>

Particulars 10 years 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1 4 34 48 33 54 60 73
Other Income 0 0 1 0 0 0 0 1 1 1
Total Income 0 0 2 4 34 48 34 54 61 74
Total Expenditure -4 -5 -14 -12 -41 -58 -52 -71 -94 -100
PBIDT -4 -5 -11 -8 -7 -9 -18 -17 -33 -26
Interest 0 -4 -1 -3 -5 -6 -6 -6 -5 -3
Depreciation -2 -4 -4 -4 -4 -5 -5 -6 -7
Taxation 0
Exceptional Items 3 0 0 -1 0
PAT -4 -8 -16 -16 -18 -20 -29 -28 -45 -36
Adjusted EPS -4 -8 -12 -11 -13 -12 -16 -14 -21 -17

Cash Flow View Details >>

Particulars 10 years 2013-06 Rs. Cr. 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -2 49 -45 -15 -11 -6 4 -36 -15 -17
Cash Fr. Inv. 6 0 -3 -4 -5 -3 -4 -10 -23 -23
Cash Fr. Finan. -4 -49 54 13 16 9 17 29 38 40
Net Change 0 0 6 -6 0 0 17 -17 1 -1
Cash & Cash Eqvt 0 0 6 0 0 0 17 0 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 70.05 70.05 72.74 72.74 72.74 72.74 72.74 72.74 72.72
Public 29.95 29.95 27.26 27.26 27.26 27.26 27.26 27.26 27.28
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 23 Jan 2023
Board Meeting Intimation for Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended December 31 2022 Of The Financial Year 2022-23
KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 inter alia to consider and approve Pursuant to Regulation 29 read with Regulation 47 of the SEBI (LODR) Regulations 2015 notice is hereby given that meeting of the Board of Directors of the Company will be held on Friday February 03 2023 inter-alia to consider and adopt the Unaudited Financial Results for the 3rd quarter and nine months ended December 31 2022 of the Financial year 2022-23. Further with reference to the above meeting of the Board of Directors we have already informed vide our letter dated December 26 2022 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations 2015 shall remain closed w.e.f December 31 2022 and until 48 hours after the declaration of the Companys unaudited financial results for the 3rd quarter and nine months ended December 31 2022 i.e. February 5 2023.
Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022
Tue, 03 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and based on the intimation received from the Companys Registrar and Transfer Agent (RTA) KFin Technologies Limited we would like to inform that the Company has received a letter from a shareholder regarding loss of share certificates along with a request to issue duplicate share certificates in lieu thereof.

Technical Scans View Details >>

Fri, 27 Jan 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Krebs Biochemicals & Industries Ltd.

What is Krebs Biochem.&Inds share price?

Can I buy Krebs Biochem.&Inds shares now?

What is the Market Cap of Krebs Biochem.&Inds?

What is the 52 Week High and Low of Krebs Biochem.&Inds?

What is the trend of Krebs Biochem.&Inds share price?